AÇAlev Çınar

Alev Çınar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alev Çınar has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Symptom–metabolic topography on brain fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography: associations between presenting clinical features and regional hypometabolism

    by Alev Çınar, Aslı Ayan

    Aims: Brain 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) provides functional information on regional cerebral glucose metabolism and may support evaluation of cognitive impairment. This study investigated associations between presenting clinical features and the topographic distribution of CortexID-derived regional hypometabolism in patients undergoing dementia-related brain 18F-FDG PET/CT. Methods: This retrospective exploratory study included 53 patients scanned at a tertiary referral center between January 2017 and January 2021. Presenting clinical features were coded as present or absent, and images were assessed visually and by CortexID semiquantitative analysis. Regions with a Z-score ≤-2.5 were classified as significantly hypometabolic. Associations were evaluated using Fisher’s exact test, odds ratios with 95% confidence intervals, Benjamini–Hochberg false discovery rate (FDR) correction, Spearman rank correlation, and supportive age- and gender-adjusted logistic regression. Results: The mean age was 66.1±4.7 years, and 46 patients (86.8%) were male. Memory complaint was most frequent (69.8%) and showed nominal associations with parietal, temporal, and combined parietotemporal patterns, whereas speech disturbance showed nominal associations with frontal hypometabolism, particularly the left frontal region. These associations remained directionally consistent in age- and gender-adjusted models but none survived FDR correction across the complete regional or composite-pattern families (lowest adjusted q=0.103). Symptom burden was uncorrelated with the number of threshold positive hypometabolic regions (Spearman ρ=0.035, p=0.805). Conclusion: Presenting memory and speech-related symptoms showed anatomically coherent but multiplicity-sensitive associations with regional hypometabolic topography on brain 18F-FDG PET/CT. These hypothesis-generating findings support prospective investigation using standardized neuropsychological phenotyping, continuous quantitative PET measures, and independent etiological characterization.

  • Open Access

    Disincronía ventricular izquierda en pacientes con disfunción diastólica

    by Alev Cinar, Derya Cayir, Kursat Okuyucu

    El contenido completo estará disponible en breve. ¡Gracias por tu paciencia!

  • Open Access

    From a favorable laboratory profile to RAI-related outcomes: extending the evidence for LT3-assisted withdrawal

    by Alev Çınar

    Levotriiodothyronine (LT3)-assisted withdrawal may improve short-term tolerability during hypothyroidism induction in patients with differentiated thyroid carcinoma undergoing preparation for radioactive iodine therapy. Recent findings suggest a more favorable laboratory profile while maintaining adequate thyroid-stimulating hormone stimulation. However, adequate TSH elevation remains a surrogate marker and does not directly establish therapeutic effectiveness. Future comparative studies should therefore determine whether the biochemical advantages of LT3-assisted withdrawal are accompanied by preserved radioactive iodine–related outcomes. Relevant endpoints may include post-therapy imaging findings, longitudinal thyroglobulin and anti-thyroglobulin antibody measurements, structural and biochemical response categories, and predefined ablation or follow-up outcomes. Integrating laboratory tolerability with clinically meaningful radioactive iodine endpoints would clarify whether LT3-assisted withdrawal represents not only a more tolerable but also an oncologically sound preparation strategy for patients with differentiated thyroid carcinoma.

  • Baseline fdg pet/ct-derived tumor burden and host metabolic activity predict complete metabolic response to neoadjuvant chemotherapy in ınvasive ductal breast cancer

    by Alev Cinar, Semra Demirtas Senlik, Ayberk Inanir, Ebru Tatcı, Ozlem Ozmen

    Purpose To evaluate the prognostic significance of FDG PET/CT-derived tumor burden, host metabolic activity, inflammatory biomarkers, and body composition parameters for predicting complete metabolic response (CMR) following neoadjuvant chemotherapy (NAC) in patients with invasive ductal breast cancer. Materials and methods Ninety women with histologically confirmed invasive ductal breast cancer who underwent baseline and post-treatment FDG PET/CT examinations following NAC were retrospectively included. Metabolic tumor volume (MTV), total lesion glycolysis (TLG), brain-to-liver ratio (Brain/LR), bone marrow-to-liver ratio (BM/LR), neutrophil-to-lymphocyte ratio (NLR), and psoas muscle-to-subcutaneous fat thickness ratio (PS/SCFT) were analyzed. Correlation analyses, multivariable regression analyses, and ROC analyses were performed. Results CMR was achieved in 77 patients (85.6%), whereas 13 patients (14.4%) demonstrated residual metabolic disease. Baseline MTV and TLG were significantly higher in non-CMR patients (p=0.024 and p = 0.004, respectively). Brain/LR was significantly lower in non-responders (p = 0.007). Ki-67 demonstrated a significant inverse correlation with MTV (ρ = − 0.309, p = 0.003). In multivariable regression analysis, baseline BM/LR (β = 0.363, p = 0.017) and baseline PS/SCFT (β = − 0.268, p = 0.017) independently predicted post-treatment SUVmax. ROC analysis demonstrated AUC values of 0.705 for MTV, 0.757 for TLG, 0.734 for Brain/LR, and 0.864 for the combined predictive model. Conclusion Baseline volumetric tumor burden is strongly associated with metabolic response following NAC. Integration of tumor burden parameters with host metabolic and body composition biomarkers may improve individualized treatment-response prediction in breast cancer.

  • Open Access

    Colorectal cancers metastases clinicopathology, and PET/CT

    by Alev Cinar, Derya Cayir

    Objective: To investigate the difference in primary tumour locations according to the organs to which colorectal cancers metastasised. Method: The retrospective study was conducted at the Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkiye, and comprised data from January 2011 to January 2021 of metastatic colorectal cancer patients. The data was divided into three groups based on their primary tumour locations as per the positron emission tomography and computed tomography images. The ascending colon and transverse colon were categorised as right-sided and placed in group 1, the descending colon and sigmoid colon were categorised as left-sided and placed in group 2, while rectal cancers were placed in group 3. The groups were compared in terms of the organs to which their cancer metastasised. Data was analysed using SPSS 15. Results: Of the 83 patients, 52(62.6%) were males and 31(37.4%) were females. The overall mean age was 63.58±10.2 years (range: 34-87 years). There were 44(53%) patients in group 1, 22(26.5%) in group 2, and 17(20.5%) in group 3 (p=0.053). Liver alone encountered metastases in 48(57.8%) cases. The frequency of only lung metastasis, and only liver metastasis in group 1 was higher than the other groups (p=0.001). There was no significant difference among the groups in terms of synchronous metastatic spread of cancer to both the liver and the lungs (p=0.031). Conclusion: The right-sided colon tumours had a higher potential to metastasise compared to the other colon cases. Key Words: Colorectal cancer, Metastases physiology, PET, CT.

  • Open Access

    Association Of Myocardial Perfusion Scintigraphy Findings With Traditional Cardiovascular Risk Factors And Heartscore

    by Semra Demirtaş Şenlik, Alev Çınar, Aysu Dursun, Seda Gülbahar Ateş, Derya Çayır

    Cardiovascular diseases are the leading global cause of morbidity and mortality, primarily due to ischemic heart disease. This study aims to investigate the relationship between myocardial perfusion scintigraphy (MPS) findings and HeartScore values, and to evaluate its association with conventional cardiovascular risk factors. In our study, patients who were referred to the Department of Nuclear Medicine for MPS between April 1 and June 30, 2024, were included. Demographic and clinical data were collected from pre-scan anamnesis forms, including age, sex, diabetes mellitus (DM), hypercholesterolemia (HL), body mass index (BMI), coronary artery disease (CAD), smoking status, and family history. HeartScore values were calculated in a total of 144 patients, including 79 (all eligible for HeartScore calculation) with ischemia and 65 randomly selected controls without ischemia, to estimate the 10-year cardiovascular risk. A p-value of < 0.05 was considered statistically significant. Out of the 1,509 patients evaluated, MPS identified ischemia in 228 cases, infarction in 40, and normal perfusion in 1,241. A statistically significant increase in the incidence of ischemia was observed in parallel with rising HeartScore values (p = 0.008). MPS findings were significantly associated with the presence of CAD, HL and BMI (p < 0.05). However, no statistically significant association was found with DM. The significant association between MPS findings and estimated future cardiovascular risk supports the use of HeartScore as a valuable pre-screening tool. The presence of known risk factors, particularly CAD and HL, significantly increased the likelihood of ischemia on MPS, whereas BMI was inversely associated.

  • Open Access

    https://mirt.tsnmjournals.org/articles/metastatic-prostate-cancer-with-pulmonary-involvement-mimicking-pneumonia-findings-on-lesssupgreater18lesssupgreaterf-fdg-petct-and-lesssupgreater68lesssupgreaterga-psma-petct/doi/mirt.galenos.2025.79053

    by Nur Aydınbelge Dizdar, Ebru Tatcı, Alev Noyaner Çınar, Büşra Bozca, Özlem Özmen

    Metastatic Prostate Cancer with Pulmonary Involvement Mimicking Pneumonia: Findings on 18F-FDG PET/CT and 68Ga-PSMA PET/CT - Molecular Imaging and Radionuclide Therapy

  • Open Access

    Comparison of multiparametric prostate MR imaging and Ga-68 PSMA PET-CT imaging in prostate cancer staging

    by Can Sicimli, Selahattin Bedir, Alev Çınar, Kemal Niyazi Arda

    Background/Aim: Staging in prostate cancer is essential for determining the right treatment approach and its execution. This study assessed the staging effectiveness of multiparametric prostate magnetic resonance imaging (MpMRI) compared to prostate-specific membrane antigen (PSMA) positron emission tomography – computed tomography (PET-CT) and examined the preoperative information that they provide. Methods: We collected data from patients diagnosed with prostate cancer who visited our clinic between June 2020 and November 2022. The results from MpMRI performed prior to biopsy were compared to those from PSMA PET-CT conducted after diagnosis, alongside the outcomes of pathological evaluations. Results: There was no significant correlation between MpMRI and PSMA PET-CT findings and the final pathology results regarding extraprostatic extension. However, both imaging techniques showed a significant correlation with the final pathology in evaluating pelvic lymph-node metastasis and seminal vesicle invasion. In terms of lesion localization, no significant correlation was found between the final site of the pathological lesion and MpMRI, while a significant correlation was noted with PSMA PET-CT. Patients with positive surgical margins had significantly elevated serum PSA levels, size of the index lesion identified in MpMRI, and maximum standardized uptake values (SUV max) of PSMA. Conclusion: Although both imaging methods offer important staging insights, further research is needed to clarify their respective limitations and benefits. In the future, these techniques may have additional roles in predicting surgical margin positivity before surgery.